Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Nasdaq Down Over 50 Points; Uber Posts Q1 Loss

Published 08/05/2024, 15:02
Updated 08/05/2024, 16:10
© Reuters.  Nasdaq Down Over 50 Points; Uber Posts Q1 Loss
UK100
-
US500
-
FCHI
-
DE40
-
ES35
-
STOXX50
-
HK50
-
GC
-
SI
-
IXIC
-
SSEC
-
UBER
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Wednesday.

Following the market opening Wednesday, the Dow traded down 0.05% to 38,863.85 while the NASDAQ fell 0.37% to 16,272.05. The S&P 500 also fell, dropping, 0.17% to 5,179.08.

Check This Out: Top 2 Financial Stocks That May Fall Off A Cliff In May

Leading and Lagging Sectors

Utilities shares rose by 0.2% on Wednesday.

In trading on Wednesday, real estate shares fell by 0.9%.

Top Headline

Uber Technologies, Inc (NYSE:UBER) posted weaker-than-expected fiscal first-quarter financial results.

Uber reported fiscal first-quarter 2024 revenue growth of 15% year-on-year to $10.10 billion, marginally missing the analyst consensus estimate of $10.11 billion. Uber’s GAAP EPS of 32 cents loss missed the analyst consensus estimate of 23 cents.

Equities Trading UP

Reborn Coffee, Inc. (NASDAQ:REBN) shares shot up 104% to $3.53 after the company announced a significant expansion into the China market through a strategic Master License Agreement with IAID Co.

Shares of iSun, Inc. (NASDAQ:ISUN) got a boost, surging 44% to $0.1904.

Innodata Inc. (NASDAQ:INOD) shares were also up, gaining 39% to $9.35 after the company reported a year-over-year increase in first-quarter financial results.

Equities Trading DOWN

Treace Medical Concepts, Inc.. (NASDAQ:TMCI) shares dropped 60% to $4.46 after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.

Shares of DoubleVerify Holdings, Inc. (NYSE:DV) were down 40% to $18.46 after the company reported first-quarter financial results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Seres Therapeutics, Inc. (NASDAQ:MCRB) was down, falling 35% to $0.7181 following quarterly results.

Also Check This Out: How To Earn $500 A Month From Maximus Stock Ahead Of Q2 Earnings

Commodities

In commodity news, oil traded down 0.9% to $77.69 while gold traded down 0.2% at $2,319.80.

Silver traded down 0.1% to $27.505 on Wednesday, while copper fell 1.3% to $4.5395.

Euro zone

European shares were higher today. The eurozone's STOXX 600 rose 0.2%, Germany's DAX rose 0.1% and France's CAC 40 gained 0.7%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 rose 0.3%.

Spain’s industrial output declined by 1.2% year-over-year in March compared to a revised 1.3% gain in the previous month. German industrial production fell by 0.4% month-over-month in March versus a revised 1.7% increase in the earlier month.

Asia Pacific Markets

Asian markets closed lower on Wednesday, with Japan's Nikkei falling 1.63%, China's Composite Index declining 0.61%, Hong Kong's Hang Seng Index dipping 0.90% and India's S&P BSE Sensex falling 0.1%.

Economics

Mortgage applications in the US increased by 2.6% from the prior week in the period ending May 3.

Now Read This: Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.